Spinal 5-HT7 receptors and protein kinase A constrain intermittent hypoxia-induced phrenic long-term facilitation

Neuroscience. 2013 Oct 10:250:632-43. doi: 10.1016/j.neuroscience.2013.06.068. Epub 2013 Jul 11.

Abstract

Phrenic long-term facilitation (pLTF) is a form of serotonin-dependent respiratory plasticity induced by acute intermittent hypoxia (AIH). pLTF requires spinal Gq protein-coupled serotonin-2 receptor (5-HT2) activation, new synthesis of brain-derived neurotrophic factor (BDNF) and activation of its high-affinity receptor, TrkB. Intrathecal injections of selective agonists for Gs protein-coupled receptors (adenosine 2A and serotonin-7; 5-HT7) also induce long-lasting phrenic motor facilitation via TrkB "trans-activation." Since serotonin released near phrenic motor neurons may activate multiple serotonin receptor subtypes, we tested the hypothesis that 5-HT7 receptor activation contributes to AIH-induced pLTF. A selective 5-HT7 receptor antagonist (SB-269970, 5mM, 12 μl) was administered intrathecally at C4 to anesthetized, vagotomized and ventilated rats prior to AIH (3, 5-min episodes, 11% O2). Contrary to predictions, pLTF was greater in SB-269970 treated versus control rats (80 ± 11% versus 45 ± 6% 60 min post-AIH; p<0.05). Hypoglossal LTF was unaffected by spinal 5-HT7 receptor inhibition, suggesting that drug effects were localized to the spinal cord. Since 5-HT7 receptors are coupled to protein kinase A (PKA), we tested the hypothesis that PKA inhibits AIH-induced pLTF. Similar to 5-HT7 receptor inhibition, spinal PKA inhibition (KT-5720, 100 μM, 15 μl) enhanced pLTF (99 ± 15% 60 min post-AIH; p<0.05). Conversely, PKA activation (8-br-cAMP, 100 μM, 15 μl) blunted pLTF versus control rats (16 ± 5% versus 45 ± 6% 60 min post-AIH; p<0.05). These findings suggest a novel mechanism whereby spinal Gs protein-coupled 5-HT7 receptors constrain AIH-induced pLTF via PKA activity.

Keywords: AIH; ANOVA; BDNF; MAP; NADPH; PETCO(2); PKA; ROS; acute intermittent hypoxia; analysis of variance; brain-derived neurotrophic factor; end-tidal carbon dioxide partial pressures; hypoxia; long-term facilitation; mean arterial pressures; motor neuron; nicotinamide adenine dinucleotide phosphate; pLTF; pMF; phrenic; phrenic long-term facilitation; phrenic motor facilitation; protein kinase A; reactive oxygen species; respiratory control; respiratory plasticity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Arterial Pressure / drug effects
  • Arterial Pressure / physiology
  • Blood Gas Analysis
  • Carbazoles / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Data Interpretation, Statistical
  • Enzyme Inhibitors / pharmacology
  • Hypoglossal Nerve / physiology
  • Hypoxia / enzymology
  • Hypoxia / metabolism*
  • Injections, Spinal
  • Long-Term Potentiation / physiology*
  • Male
  • NADPH Oxidases / metabolism
  • Phenols / pharmacology
  • Phrenic Nerve / physiology*
  • Pyrroles / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor Cross-Talk / physiology
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / metabolism*
  • Serotonin Antagonists / pharmacology
  • Spinal Cord / drug effects
  • Spinal Cord / enzymology
  • Spinal Cord / metabolism*
  • Sulfonamides / pharmacology

Substances

  • Carbazoles
  • Enzyme Inhibitors
  • Phenols
  • Pyrroles
  • Receptors, G-Protein-Coupled
  • Receptors, Serotonin
  • SB 269970
  • Serotonin Antagonists
  • Sulfonamides
  • serotonin 7 receptor
  • KT 5720
  • NADPH Oxidases
  • Cyclic AMP-Dependent Protein Kinases